Xofluza
NDC 50242-860, BALOXAVIR MARBOXIL, tablet, film coated, from Genentech, Inc..
- Product NDC
- 50242-860
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210854
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BALOXAVIR MARBOXIL40 mg/1
Pharmacologic classes
Chelating Activity [MoA]; Polymerase Acidic Endonuclease Inhibitor [EPC]; Polymerase Acidic Endonuclease Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-860-01 | 50242086001 | 1 BLISTER PACK in 1 CARTON (50242-860-01) / 1 TABLET, FILM COATED in 1 BLISTER PACK |
| 50242-860-86 | 50242086086 | 1 BLISTER PACK in 1 CARTON (50242-860-86) / 1 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e49e1a61-1b7c-4be5-ac84-af6240b511e7NADAC price for package 50242086001
GET /v1/drugs/nadac/50242086001
Use it
Look up 50242-860 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-860. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.